Zydus Lifesciences’ arm inks share purchase agreement to acquire stake in Mylab

24 Jun 2023 Evaluate

Zydus Lifesciences’ wholly owned subsidiary -- Zydus Animal Health and Investments (ZAHL) has entered into a Share Purchase Agreement (SPA) with Rising Sun Holdings (Seller) and Mylab Discovery Solutions (Target) to acquire 65,06,500 equity shares having face value of Re 1 each (which are fully paid-up) at an agreed consideration of Rs 106 crore representing 6.5% of the total paid-up equity share capital of Mylab from the Seller. The ultimate number of shares to be held can change, as per the terms of the Agreement, based on the financial performance of Mylab for the year ending on March 31, 2024.

The proposed investment in Mylab will help the company to participate in growing diagnostics space which is expected to witness increased penetration through in-clinic solutions with Point of Care Testing (POCT) devices.

Zydus Lifesciences (formerly known as Cadila Healthcare) is an India-based pharmaceutical company.


Zydus Lifesciences Share Price

911.20 -6.25 (-0.68%)
26-Dec-2025 12:09 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1711.50
Dr. Reddys Lab 1266.05
Cipla 1504.90
Zydus Lifesciences 911.20
Lupin 2104.10
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×